Biden Announces Califf Chosen to Lead FDA

President BidenJoe BidenBiden and Xi of China to hold virtual summit on Monday: Briahna Joy Gray reports: Biden ‘plays dumb’ with cancellation of student debt Defense and national security – Biden celebrates Veterans Day MORE on Friday he appointed former Obama administration official and Duke University professor Robert Califf to head the Food and Drug Administration (FDA).

Califf’s election comes after a months-long delay in selecting an FDA commissioner, drawing some criticism given the agency’s role in helping fight the COVID-19 pandemic. Califf is a familiar face, having led the agency at the end of the Obama administration.

“Dr. Robert Califf is one of the most experienced clinical researchers in the country and has the experience and expertise to lead the Food and Drug Administration during a critical time in our nation’s fight to end the coronavirus pandemic. “said Biden. in a sentence. “As the FDA considers many consequential decisions around vaccine approvals and more, it is critical that we have a strong, independent hand to guide the FDA.

“I am confident that Dr. Califf will ensure that the FDA continues its science and data-based decision making. Dr. Califf had strong bipartisan support in the Senate in 2016, and I urge the Senate to please quickly confirm to Dr. Califf so he can continue the important work that is being done at this critical time, “added Biden.

Califf would return for a second stint at the top of the agency if confirmed, having led for less than a year from early 2016. He was previously confirmed in a bipartisan 89-4 vote, so he could gain Republican support. again.

Some Democrats previously raised concerns about their ties to the pharmaceutical industry, as well as whether the FDA was doing enough to combat the opioid epidemic. Senator Joe manchinJoe ManchinOvernight Energy & Environment – Presented by ExxonMobil – Manchin Criticizes New Spending Bill Provision Climate Change – Hope for How (Literally) Save the World On The Money – IRS Chief Calls for Reinforcements MORE (DW.Va.) issued a statement on Friday opposing the election moments before it was officially announced, citing concerns about Califf’s ties to the pharmaceutical industry.

“Dr. Califf’s nomination and his significant ties to the pharmaceutical industry take us back, not forward,” Manchin said in a statement. “Your nomination is an insult to the many families and individuals whose lives have been forever changed as a result of addiction.”

Under federal law, Biden faced a deadline Monday to choose a leader for the agency or nominate the current acting commissioner, Janet Woodcock.

The White House has for months deflected questions about the delay in the nomination of an FDA commissioner confirmed by the Senate, saying it wanted to make sure whoever they elected could get majority support in the House. Officials believe Califf can win the support of both parties, pointing to his latest confirmation hearing and extensive experience as a doctor and investigator.

The agency has not had a Senate-confirmed leader since Biden took office in January, though it has been at the center of critical decisions surrounding the coronavirus pandemic, authorizing vaccines for children, booster doses for adults, and pondering data. on antiviral drugs to fight COVID. -19.

Califf, a longtime Duke University cardiologist, has spent the last several years working on healthcare issues at Google.

Updated: 12:30 pm



Reference-thehill.com

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *